ENGINEERING A HIGHLY POTENT AND SELECTIVE HNTX-III MUTANT AGAINST THE NAV1.7 SODIUM CHANNEL FOR TREATMENT OF PAIN

被引：0
|
作者：
Zhang, Yunxiao [1 ]
Peng, Dezheng [1 ]
Chen, Minzhi [1 ]
Li, Jiayan [1 ]
Li, Dan [1 ]
Liu, Zhonghua [1 ]
Liang, Songping [1 ]
机构：
[1] Hunan Normal Univ, Natl &Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China
来源：
TOXICON | 2019年 / 158卷
关键词：
Nav1.7; HNTX-III; Analgesia; Structure activity relationship;
D O I：
10.1016/j.toxicon.2018.10.195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
186
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [31] Computational design of peptides to target Nav1.7 channel with high potency and selectivity for the treatment of pain
    Nguyen, Phuong T.
    Nguyen, Hai M.
    Wagner, Karen M.
    Stewart, Robert
    Singh, Vikrant
    Thapa, Parashar
    Ton, Anh Tuan
    Kondo, Richard P.
    Ghetti, Andre
    Pennington, Michael W.
    Hammock, Bruce
    Griffith, Theanne N.
    Sack, Jon T.
    Wulff, Heike
    Yarov-Yarovoy, Vladimir
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 309A - 309A
  • [32] Discovery of clinical candidate GDC-0276: A selective NaV1.7 inhibitor for the treatment of pain
    Sutherlin, Daniel
    Sun, Shaoyi
    Chowdhury, Sultan
    Jia, Qi
    Zenova, Alla
    Wilson, Michael
    Focken, Thilo
    Li, Jun
    Bichler, Paul
    Decker, Shannon
    Grimwood, Mike
    Hemeon, Ivan
    Sheng, Tao
    Andrez, Jean-Christophe
    Hackos, David
    Bankar, Girish
    Khakh, Kuldip
    Chang, Elaine
    Kwan, Rainbow
    Lin, Sohia
    Nelkenbrecher, Karen
    Ortwine, Daniel
    Chang, Jae
    Pang, Jodie
    Sojo, Luis
    Chiang, Po-chang
    Sambrone, Amy
    Tagen, Michael
    White, Andrew
    Chen, Chien-An
    Chen, John
    Lovelidge, Jane
    Ding, Xiao
    Takahashi, Ryan
    Waldbrook, Matthew
    Xie, Zhiwei
    Young, Clint
    Robinette, Lee
    Cohen, Charles
    Oballa, Renata
    Dehnhardt, Christoph
    Safina, Brian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [33] Computational design of peptides to target NaV1.7 channel with high potency and selectivity for the treatment of pain
    Nguyen, Phuong T.
    Nguyen, Hai M.
    Wagner, Karen M.
    Stewart, Robert G.
    Singh, Vikrant
    Thapa, Parashar
    Chen, Yi-Je
    Lillya, Mark W.
    Ton, Anh Tuan
    Kondo, Richard
    Ghetti, Andre
    Pennington, Michael W.
    Hammock, Bruce
    Griffith, Theanne N.
    Sack, Jon T.
    Wulff, Heike
    Yarov-Yarovoy, Vladimir
    ELIFE, 2022, 11
  • [34] Structure-based drug discovery in a sodium channel: Discovery of chromane arylsulfonamide Nav1.7 inhibitors for the treatment of chronic pain
    McKerrall, Steven
    Bergeron, Philippe
    Safina, Brian
    Ortwine, Daniel
    Shields, Shannon
    Deng, Lunbin
    Hackos, David
    Chen, Jun
    Pang, Jodie
    Chang, Jae
    Lai, Kwong
    Liu, Wenfeng
    Liu, Zhiguo
    Dehnhardt, Christoph
    Johnson, J. P.
    Bankar, Girish
    Cohen, Charles
    Sutherlin, Daniel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [35] The ubiquitin ligase Nedd4-2 is a potent regulator of the voltage-gated sodium channel Nav1.7 and is implicated in neuropathic pain
    Cedric, Laedermann
    Matthieu, Cachemaille
    Hugues, Abriel
    Isabelle, Decosterd
    SWISS MEDICAL WEEKLY, 2011, 141 : 15S - 15S
  • [36] Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7
    Kornecook, Thomas J.
    Yin, Ruoyuan
    Altmann, Stephen
    Be, Xuhai
    Berry, Virginia
    Ilch, Christopher P.
    Jarosh, Michael
    Johnson, Danielle
    Lee, Josie H.
    Lehto, Sonya G.
    Ligutti, Joseph
    Liu, Dong
    Luther, Jason
    Matson, David
    Ortuno, Danny
    Roberts, John
    Taborn, Kristin
    Wang, Jinti
    Weiss, Matthew M.
    Yu, Violeta
    Zhu, Dawn X. D.
    Fremeau, Robert T., Jr.
    Moyer, Bryan D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362 (01): : 146 - 160
  • [37] A NEW NAV1.7 SODIUM CHANNEL HAPLOTYPE ASSOCIATED WITH RESPONSIVENESS TO DULOXETINE: A PHARMACOGENOMICS STUDY OF NEUROPATHIC PAIN THERAPY
    Kapetis, D.
    Pierro, T.
    Galbardi, B.
    Lauria, G. P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 : S17 - S17
  • [38] The voltage-gated sodium channel NaV1.7 underlies endometriosis-associated chronic pelvic pain
    Castro, Joel
    Maddern, Jessica
    Chow, Chun Yuen
    Tran, Poanna
    Vetter, Irina
    King, Glenn F.
    Brierley, Stuart M.
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (11) : 3760 - 3776
  • [39] Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity
    Kerth, Clara M.
    Hautvast, Petra
    Koerner, Jannis
    Lampert, Angelika
    Meents, Jannis E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [40] Ciguatoxins Evoke Potent CGRP Release by Activation of Voltage-Gated Sodium Channel Subtypes NaV1.9, NaV1.7 and NaV1.1
    Touska, Filip
    Sattler, Simon
    Malsch, Philipp
    Lewis, Richard J.
    Reeh, Peter W.
    Zimmermann, Katharina
    MARINE DRUGS, 2017, 15 (09):
12345